The QualityStocks Daily Thursday, November 15th, 2018

Today's Top 3 StockMarketWatch

Shiznit Stocks (AGHI) +38.10%

QualityStocks (GSPH) +36.65%

StockMarketWatch (QURE) +35.66%

The QualityStocks Daily Stock List

Sun BioPharma, Inc. (SNBP)

AheadoftheBulls, Lebed, Today's Financial News, HotPennyStocksNow, OTC Picks, Beacon Equity Research, AllPennyStocks, TheStockWizards, The Dean, FeedBlitz, MicrocapVoice, Hot Shot Stocks, Wall Street Resources, Greenbackers, CoolPennyStocks, Otcstockexchange, and HotOTC reported earlier on Sun BioPharma, Inc. (SNBP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sun BioPharma, Inc. is a Biopharmaceutical Company headquartered in Waconia, Minnesota. It is developing disruptive therapeutics for the treatment of patients with pancreatic diseases. A clinical-stage biopharmaceutical business, Sun BioPharma’s development programs target diseases of the pancreas. This includes pancreatic cancer and pancreatitis. Sun BioPharma’s shares trade on the OTC Markets Group’s OTCQB.

Sun BioPharma has scientific collaborations with pancreatic disease experts at Cedars Sinai Medical Center in Los Angeles, California; the University of Miami; the University of Florida; the Mayo Clinic Scottsdale; the Austin Health Cancer Trials Centre and the Box Hill Hospital in Melbourne, Australia, and the Ashford Cancer Centre in Adelaide, Australia.

Sun BioPharma’s first product candidate is SBP-101. This product is for the treatment of patients with pancreatic cancer. Mr. Ray Bergeron, Ph.D. Distinguished Professor Emeritus, University of Florida invented SBP-101.The Company’s plan is to develop SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.

SBP-101 is a first-in-class, proprietary, polyamine compound. The design of it is to exert therapeutic effects in a mechanism specific to the pancreas. The Company originally licensed SBP-101 from the University of Florida in 2011.

Furthermore, Sun BioPharma’s SBP-102 is now in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. Additionally, the Company’s SBP-103 is currently in non-clinical exploratory evaluation.

Sun BioPharma earlier announced the completion of the first-in-human safety study of SBP-101 in previously treated patients with pancreatic ductal adenocarcinoma (PDA). SBP-101 was well tolerated. In addition, signals of efficacy were observed at dose levels below the Maximum Tolerated Dose (MTD).

Sun BioPharma’s newest trial, a Phase 1a/1b combination of SBP-101 to be administered with gemcitabine and nab-paclitaxel in previously untreated patients with metastatic pancreatic ductal adenocarcinoma (PDA), enrolled the first patients on June 13, 2018. Patients were enrolled at the Adelaide Cancer Centre in Adelaide, Australia under the direction of Associate Professor Dusan Kotasek and at the University of Florida Health Cancer Center in Gainesville, Florida under the direction of Thomas J. George, MD, F.A.C.P.

Sun BioPharma’s Phase 1a/1b combination of SBP-101 with gemcitabine and nab-paclitaxel in patients previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), continued to enroll patients in the quarter ended September 30, 2018. The Phase 1a portion of this study will treat up to 18 PDA patients in three cohorts to ascertain a recommended dose of SBP-101 to be given in combination with standard treatment. The Phase 1b portion will be an expansion at the recommended dose of SBP-101. It will guide SBP-101’s subsequent development for patients with PDA.

Sun BioPharma, Inc. (SNBP), closed Thursday's trading session at $4.00, up 19.40%, on 1,530 volume with 3 trades. The average volume for the last 3 months is 238 and the stock's 52-week low/high is $1.00/$16.00.

chart

Alpine 4 Technologies Ltd. (ALPP)

Investors Hangout, Uptick Newswire, Wallet Investor, GuruFocus, TradingView, InvestorsHub, OTC Markets, Barchart, Stockhouse, MarketWatch, Proactive Investors, Market Screener, Financial Content, Investor Place, and Capital Cube reported previously on Alpine 4 Technologies Ltd. (ALPP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Alpine 4 Technologies Ltd. is a technology and manufacturing holding company. It has business-related endeavors in Automotive Technologies, Electronics Manufacturing, Software and Data Technologies. The Company formerly went by the name Alpine 4 Automotive Technologies Ltd. It changed its name to Alpine 4 Technologies Ltd. in June of 2015. Formed in 2014, Alpine 4 Technologies is based in Phoenix, Arizona.

The Company’s focus is on how the adaptation of new technologies, even in brick and mortar businesses, can boost innovation. The heart of its acquisition strategy is its emphasis on existing smaller middle market operating companies with Revenues of $5 to $50 million. The design of Alpine 4 Technologies is to allow its subsidiaries room to develop their own identities and synergistically prosper from inter-company resources and collaboration. Alpine 4 will own controlling interest in every subsidiary and it will also have direct control over planning and management.

Alpine 4’s’s subsidiaries and product groups include ALTIA; Quality Circuit Assembly (QCA); and Venture West Energy Services. ALTIA is an automotive products company. The Quality Circuit Assembly (QCA) subsidiary provides electronic contract manufacturing solutions delivered to its customers via strategic business partnerships. Venture West Energy Services focuses on supporting the oil and gas industry in Texas, Oklahoma, and Arkansas.

In 2018, Alpine 4 Technologies completed its acquisition of American Precision Fabricators, Inc. (APF).  The acquisition adds to Alpine 4’s technology manufacturing sector play that began in 2016 with its purchase of Quality Circuit Assembly (QCA). This is the fourth acquisition that Alpine 4 Technologies has made in two years.

Alpine 4 Technologies has begun two pilots of SPECTRUMebos, a blockchain Enterprise Business Operating System, in its subsidiaries Quality Circuit Assembly (QCA) and ALTIA, LLC. SPECTRUMebos is an Enterprise Business Operating System (EBOS) developed by the Company. SPECTRUMebos combines the key technology software mechanisms of Accounting and Financial Reporting of an Enterprise Resource Planning System (ERP), a Document Management System (DMS), a Business Intelligence (BI) platform and a Customer Resource Management (CRM) hub all tied to a management reporting and collaboration toolset.

Alpine 4 Technologies Ltd. (ALPP), closed Thursday's trading session at $0.07, even for the day. The average volume for the last 3 months is 24,122 and the stock's 52-week low/high is $0.0502/$0.46.

chart

DSG Global, Inc. (DSGT)

Epic Stock Picks, StockHideout, Stock Preacher, Penny Stocks Finder, SuperStockTips, Penny Stock Craze, SMS Penny Picks, eliteotc.com, WININGOTC, Wall Street Beauties, StockRockandRoll, The Observer, OTC Markets, PennyStockLocks.com, ResearchOTC, InvestorSoup, and Beacon Equity Research reported previously on DSG Global, Inc. (DSGT), and we report on the Company today, here at the QualityStocks Daily Newsletter.

DSG Global, Inc. is a technology development company whose shares trade on the OTCQB. The Company engages in the design, manufacture, and marketing of fleet management solutions for the golf industry, and also commercial, government, and military applications worldwide. DSG Global has historically concentrated on the golf industry. It has grown to become a leader in the Fleet Management category in the golf industry. DSG Global is based in Surrey, British Columbia.

The Company provides patented electronic tracking systems and fleet management solutions to golf courses. These allow for remote management of the course's fleet of golf carts, turf equipment, as well as utility vehicles. DSG is best known for its advanced GPS TAG System for golf cart and turf equipment fleet management.

DSG Global’s technology is installed in more than 10,000 vehicles on golf courses globally. The Company has an installed base of daily-fee and resort golf courses. Its cart-mounted Touch® display screens seamlessly deliver banner advertisements and full-motion videos while on the golf course.

Fundamentally, golf course operators manage their fleet of golf carts, turf equipment, and utility vehicles remotely, using DSG Global’s SaaS (Software as a Service) technology and advanced GPS hardware. DSG has acquired Impact Tournament Solutions, along with Impact’s team of experts, to run the Tournament Solutions Division of DSG Global.

DSG Global is currently branching into several new streams of revenue via programmatic advertising, licensing, and distribution. Additionally, the Company is expanding into Commercial Fleet Management and Agricultural applications. It realized record European sales in 2017 because of new installation contracts with top rated European Golf Management businesses. Furthermore, DSG Global is expanding into Raptor Single Rider Golf Car and 100E Fully Loaded Mullen Golf Cars, 2 and 4 seaters and Agricultural applications.

DSG Global has officially partnered with golf course video flyover company, STEADY MOTION. This is to bring the best interactive flyover videos to the golf sports industry. These flyover videos include professional, broadcast television quality audio narration, advanced color correction, and interactive course tours ready to be displayed on the DSG TOUCH screens and on golf course web portals.

Last month, DSG Global announced that it is introducing to the global market the first ever Infinity 12" High Definition display. This display is equipped with streaming music, video, Bluetooth, stock market and sports scores, and the top-graded flyovers in the nation, credit card tap availability, dual speakers and Programmatic Advertising.

Furthermore, last month, DSG Global announced that it has taken first steps to move towards exploring potential use cases, which it has identified for blockchain and its related technologies to be applied to the golf industry.

Mr. Robert Silzer, DSG Global’s Chief Executive Officer, stated, "Blockchain will definitely change the golf industry and DSG plans to play a leading role to bring this change to fruition. I believe this technology will revitalize the golf industry. It can build a new bridge between golf and the millennials and raise new enthusiasm for the sport. It can release tremendous value that is currently untapped."

DSG Global, Inc. (DSGT), closed Thursday's trading session at $0.0009, up 28.57%, on 119,028,814 volume with 147 trades. The average volume for the last 3 months is 46,371,526 and the stock's 52-week low/high is $0.0006/$0.0083.

chart

GB Sciences, Inc. (GBLX)

Tip.us, SeriousTraders, Pumps and Dumps, PennyStockLaboratory, Whisper from Wall Street, Stockgoodies, SmallCapVoice, Cannabis Financial Network News, Money Morning, Otcstockexchange, PennyStockInformer, StocksToBuyNow, Wall St Report, CFN Media Group, AllPenny Stocks, Wall Street Resources and TradeThesePicks reported on GB Sciences, Inc. (GBLX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GB Sciences, Inc. is a biopharmaceutical Research and Development (R&D) company. Its focus is on creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target an assortment of medical conditions. GB Sciences’ R&D team is pursuing new formulations derived from specific strains of cannabis, creating patented formulations that will help patients. GB Sciences has its corporate office in Las Vegas, Nevada.

The primary directive of the Company since its inception has been the creation of a quality-controlled cannabis cultivation and extraction facility to provide the compounds for formulating medicines to treat a broad variety of diseases. GB Sciences has added its own medical-grade retail brand to its portfolio. This portfolio includes granted-medical and provisional-recreational use Nevada cultivation licenses and patent-pending medical formulations.

GB Sciences has its Cultivation Lab facility in Las Vegas. When completely operational, Cultivation Lab will contain 7,200 cannabis plants under 600 grow lights within its 28,000 ft. The expectation is that Cultivation Lab will generate roughly $10 million in annual revenue. GB Sciences announced in February 2018 that it was issued its production license and started full production operations in the Las Vegas facility.

GB Sciences and Cura Cannabis Solutions executed a production agreement to produce high quality cannabis oils and related products using the GB Sciences production license operated by the GB Sciences' Cultivation Labs™. Cura Cannabis Solutions is the leading provider of premium cannabis oil and hemp oil to the legal domestic and international markets. The production agreement guarantees GB Sciences a set royalty on every gram produced and sold under the agreement.

Last month, GB Sciences announced the harvesting of its initial hemp crop in association with the Colorado Hemp Project. Following closely on the overall philosophy and strategy of GB Sciences, hemp is planned to provide a reliable source of hard to find cannabinoids and terpenes required to manufacture cannabis-based medical formulations and provide a new revenue source through the sale of bulk hemp oil and other hemp related products.

Yesterday, GB Sciences announced that it signed a binding Letter of Intent (LOI) with 4EVERGRN, LLC in Oklahoma. 4EVERGRN has been awarded cultivation, processing and dispensary licenses by the Oklahoma Medical Marijuana Authority. With this agreement, GB Sciences will design a cultivation and processing facility in Oklahoma and provide 4EVERGRN with best-practice operating procedures. 4EVERGRN will produce and distribute GB Sciences’ products and brands under a licensing agreement in exchange for a royalty to GB Sciences.

GB Sciences, Inc. (GBLX), closed Thursday's trading session at $0.23245, up 0.19%, on 639,286 volume with 172 trades. The average volume for the last 3 months is 1,949,936 and the stock's 52-week low/high is $0.2129/$1.5599.

chart

BioSolar, Inc. (BSRC)

Stock Roach, Stock Preacher, Penny Stock Rumble, Beacon Equity Research, TheLightningPicks, HoleinOneStocks.net, Investor News Source, StockHideout, TopPennyStockMovers, PennyTrader Publisher, OTCPicks, MicroStockProfit, and BioSolar Newsletter reported earlier on BioSolar, Inc. (BSRC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioSolar, Inc. is developing an inventive technology to increase the storage capacity, reduce the cost, and extend the life of lithium-ion batteries. The Company initially focused its development effort on high capacity cathode materials since most of contemporary Li-ion batteries are "cathode limited." With the objective of creating BioSolar’s next generation super battery technology, the Company is presently investigating high capacity anode materials. BioSolar has its corporate headquarters in Santa Clarita, California.

BioSolar has its BioBackSheet®. The Company is the leading commercial provider of bio-based solar panel backsheets. A backsheet is a required insulating film in all solar photovoltaic panels. Its primary purpose is to protect the solar panel components, specifically the solar cells and wires. The Company’s BioBackSheet® is the only commercially available Underwriters Laboratory (UL) certified bio-based backsheet.

The Company is developing BioSolar supercapacitors. This is technology for lessening the cost of storing the energy of the sun. BioSolar co-owns the patent-application for this supercapacitor technology with the University of California at Santa Barbara (UCSB). The Company is funding a sponsored research program to advance its development.

Through integrating BioSolar supercapacitors as the high power front-end to battery banks, with fewer battery banks than would usually be required, daytime solar energy can be rapidly and cost-effectively stored for night-time use at a significantly lower cost. The technology will enable solar energy systems users to decrease their dependence or go completely off the electric utility power grid.

BioSolar’s management believes that use of its silicon-metal (Si-M) anode materials, currently under development, can help reduce the cost of lithium-ion batteries. The expectation is that the Company’s Si-M anode material will be much less expensive than that of the benchmark silicon-carbon anode material that is the key cost issue typically associated with battery technology. BioSolar’s belief is that its strategy of pursuing anode material advancements to support next-generation lithium-ion batteries can play an important role within the electric vehicle sector, and the broader energy storage technology industry.

In 2017, BioSolar successfully completed the laboratory phase of its silicon nanocomposite alloy anode material technology development. BioSolar (with data that suggests its technology can attain considerably higher capacity at decreased costs,) began the process of identifying potential strategic partners for commercial development of its proprietary battery technology.

In addition, BioSolar signed a Joint Development Agreement with Top Battery, a foremost lithium-ion battery manufacturer. Furthermore, BioSolar developed a proprietary additive technology. This technology has the potential to improve all kinds of silicon anode materials. This includes Si carbon composite, Si oxide type, as well as Si alloys.

Furthermore, the Company demonstrated that its additive technology exhibited substantial improvement in battery capacity and capacity retention when applied to Si anodes made from Si micro-particles, a form of raw silicon more cost effective than Si nano-particles.

BioSolar, Inc. (BSRC), closed Thursday's trading session at $0.05425, up 10.71%, on 183,702 volume with 8 trades. The average volume for the last 3 months is 196,967 and the stock's 52-week low/high is $0.011/$0.179.

chart

CV Sciences, Inc. (CVSI)

Wealth Insider Alert, Wall Street Mover, Damn Good Penny Picks, OTCtipReporter, Market Intelligence Center Alert, StreetAuthority Daily, Penny Picks, PennyStockScholar, Profitable Trader Authority, Promotion Stock Secrets, and Stock Commander reported previously on CV Sciences, Inc. (CVSI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CV Sciences, Inc. focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). A life science company, CV Sciences operates two divisions - Pharmaceuticals and Consumer Products. These divisions are supported by its medical and scientific advisory board, and state-of-the-art production facilities. In essence, the Company is a foremost supplier and manufacturer of hemp-derived phytocannabinoids, including CBD oil, and a developer of specialty pharmaceutical therapeutics.

OTCQB-listed, the Company previously went by the name CannaVEST Corp. It changed its name to CV Sciences, Inc. in January 2016. CV Sciences has main offices and facilities in Las Vegas, Nevada, and San Diego, California.

CV Sciences acquired CanX, Inc. in December 2015. CanX is a Pre-Clinical drug development company. It is concentrating on significant unmet medical needs.

CanX’s first drug candidate is CVSI-007. CVSI-007 chewing gum combines CBD and Nicotine. It is patent pending. CVSI-007 is a proprietary chewing gum. It combines synthetic CBD and nicotine to effectively treat smokeless tobacco addiction.

CV Sciences’ Pharmaceutical Division is developing synthetically-formulated cannabidiol-based medicine. It is pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications using cannabidiol as the active pharmaceutical ingredient. The Company has achieved promising preclinical results in the development of cannabinoid medicines for the treatment of an array of medical conditions.

The Company’s Consumer Products Division delivers botanical-based cannabidiol products that enhance quality of life. Each consumer products brand is backed by a formal safety review, an increasing body of case reports, as well as physicians’ recommendations.

CV Sciences also manufactures, markets, and sells plant-based CBD products under the PlusCBD brand. This is for a variety of market sectors. These include nutraceutical, beauty care, specialty foods, and vape. CV Sciences’ natural product retail channel now includes greater than 1,500 locations across the nation.

PlusCBD Oil is the top-selling brand of hemp-derived CBD oil for consumers in the natural products industry. CV Sciences had record Q4 2017 Sales of $7,242,000. This represents an increase of 126 percent versus Q4 2016. The Company had record Q4 2017 Gross Profit of $5,213,600. This represents an increase of 187 percent versus Q4 2016.

CV Sciences had record Full Year 2017 Sales of $20,679,200. This represents an increase of 87 percent versus full year 2016. The Company had record Full Year 2017 Gross Margin of $14,488,700. This represents an increase of 107 percent versus full year 2016.

CV Sciences is scheduled to host a conference call to discuss its Q1 2018 financial results on Tuesday, May 15, 2018 at 1:15pm PT/4:15pm ET. The Company’s Chief Financial Officer (CFO), Mr. Joseph Dowling, will lead the call to provide an operational and financial summary of Q1 ended March 31, 2018.

CV Sciences, Inc. (CVSI), closed Thursday's trading session at $4.53, up 11.03%, on 1,472,568 volume with 1,670 trades. The average volume for the last 3 months is 3,717,344 and the stock's 52-week low/high is $0.215/$9.19.

chart

Blow & Drive Interlock Corp. (BDIC)

Equities.com, MarketWatch, Bloomberg, TradingView, YCharts, News to Watch, and Reuters reported on Blow & Drive Interlock Corp. (BDIC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Blow & Drive Interlock Corp. provides automotive and criminal offender monitoring security products. The Company has its state‐of‐the‐art ignition interlock device: BDI-747. This device is approved and available in eight states for evidentiary and preliminary screening use.

In essence, the Company is an offender monitoring and police-grade alcohol detection device manufacturing and offender monitoring business. Blow & Drive Interlock has its corporate office in Los Angeles, California. The Company’s shares trade on the OTC Markets.

Interlocks are required for use by DUI or DWI (Driving Under The Influence or Driving While Intoxicated) offenders as part of their mandatory court or motor vehicle department program.

The Company’s BDI-747 is an ignition interlock device, breath-alcohol testing device about the size of a smartphone. The ignition interlock device requires the driver to exhale into the device prior to starting the vehicle. The device will prevent the vehicle from starting if the driver's blood-alcohol content exceeds a predetermined set level.

Blow & Drive Interlock states that its BDI-747 is the most advanced user friendly IID presently available. The BDI-747 can record BAC levels. It provides 2-way communication, GPS location technology, and image technology. Furthermore, the BDI-747 is wireless.

Blow & Drive Interlock’s aim is to have the BDI-747 available to customers across the U.S. In addition, the Company continues to do research and development (R&D) of the next stage of offender monitoring. It believes this will be smartphone enabled monitoring applications (apps), which could reduce or eliminate the need for ankle bracelets or hand-held breathalyzers.

This past May, Blow & Drive Interlock announced the hiring of Mr. JC Lopez as the New Chief Operating Officer (COO) of the Company. Mr. Lopez has more than two decades of experience in the Government sector. He offers over 10 years of accomplishment-laden experience in the Interlock Industry.

Moreover, throughout his career, he has established a strong network of contacts in the interlock community that the Company states will be an extremely valuable addition to the Blow and Drive Interlock Team, boosting sales growth, market share, as well as operations efficiency.

Blow & Drive Interlock Corp. (BDIC), closed Thursday's trading session at $0.06297, up 8.57%, on 2,500 volume with 1 trade. The average volume for the last 3 months is 15,224 and the stock's 52-week low/high is $0.0502/$0.389.

chart

CTD Holdings, Inc. (CTDH)

HotStockChat, Greenbackers, Wall Street Resources, and Nebula Stocks reported earlier on CTD Holdings, Inc. (CTDH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

CTD Holdings, Inc. is developing cyclodextrin-based products for the treatment of disease. This includes Trappsol® Cyclo™. The Company’s other divisions distribute and manufacture the trademarked Trappsol® and Aquaplex® cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes for biotechnology and life science companies engaged in the research, pharmaceutical, medical device, cosmetics, and nutrition markets. A biotechnology company, CTD Holdings has its headquarters Alachua, Florida.

CTD’s Trappsol® Cyclo™ is an orphan drug designated product. It is for the treatment of Niemann-Pick Type C (NPC). This is a rare and frequently fatal genetic disease in young children. Moreover, the disease results in major health impairment for affected adults. NPC impacts the brain, lung, liver, spleen, as well as other organs.

Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. This includes peripheral artery disease, diabetic nephropathy, and acute viral infections.

CTD Holdings’ other divisions operate the world's only cGMP pulse drying facility to produce UltraPure™ cyclodextrin derivatives and pharmaceutical grade Aquaplex® cyclodextrin complexes. Furthermore, they supply cyclodextrins to biotechnology and life science researchers around the world from the world's largest catalog of cyclodextrins.

CTD Holdings has begun a multi-center international Phase I/II clinical trial in Europe. This clinical trial is evaluating intravenous administration of Trappsol® Cyclo™ in NPC patients.

In late January 2018, CTD Holdings announced that it entered into negotiations for a cooperative research agreement with Kerwin Research Center, LLC to explore the use of cyclodextrins in the treatment of Alzheimer's disease. The principal investigator on the project will be Diana Kerwin, MD. She is a recognized expert in Alzheimer's disease and memory disorders who was formerly part of the Northwestern University, National Institute on Aging-funded, Cognitive Neurology and Alzheimer's Disease Center. There, she supervised clinical trials and clinical research. Last week, CTD Holdings announced that a single patient IND expanded access program using its proprietary formulation of hydroxypropyl beta cyclodextrin, Trappsol® Cyclo™, for the treatment of Alzheimer's disease was authorized to proceed by the US FDA (Food and Drug Administration). The IND was submitted by Diana Kerwin, MD, of the Kerwin Research Center. As part of the IND application, CTD Holdings provided Dr. Kerwin with access to its Type II Drug Master File at the FDA. CTD also provided technical input on development of the protocol. CTD will play an active role in monitoring progress of the program.

Today, CTD Holdings announced that Dr. Randall M. Toig, M.D. of Chicago, Illinois joined the Company’s Board of Directors. Dr. Toig is an Associate Professor at Northwestern University, Northwestern Memorial Hospital.

CTD Holdings, Inc. (CTDH), closed Thursday's trading session at $1.02, up 3.03%, on 35,027 volume with 22 trades. The average volume for the last 3 months is 16,075 and the stock's 52-week low/high is $0.25/$0.99.

chart

Progressive Care, Inc. (RXMD)

Penny Stock Tweets, Business Insider, Wallet Investor, Smarter Analyst, InvestorsHub, ClayTrader, Stockhouse, Street Register, Wall Street Analyzer, Zacks, First Look Equities, OTC Markets, SeeThruEquity, TradingView, OTC.Watch, 4-Traders, Investors Hangout, and Insider Financial reported earlier on Progressive Care, Inc. (RXMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Progressive Care, Inc., by way of its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization. It is moving ahead in its work to grow the Company by expanding its facility, adding new locations, acquiring operating pharmacies, and further developing its current business lines. Progressive Care is based in North Miami Beach, Florida and the Company lists on the OTCQB.

The Company is a provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities. Additionally, Progressive Care is a provider of administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.

The Company owns PharmCo LLC. PharmCo was established in 2005 as a Florida Limited Liability Corporation with the objective of becoming a premier pharmacy in the South Florida community. PharmCo has developed into a health services enterprise that concentrates on the provision of prescription pharmaceuticals.

Progressive Care opened Smart Medical Alliance, Inc. on September 1, 2016. It opened Smart Medical to assist healthcare providers with navigating the complex risk management environment of their insurance network contracts. Smart Medical Alliance provides management and support services to doctors and administrators under capitated and fee-for-services insurance contracts.

Progressive Care announced earlier in 2018 that it completed the acquisition of a Touchpoint pharmacy in Palm Beach County. This second location will enable Progressive Care’s growth by expanding the delivery radius of its pharmacy operations to now include Miami-Dade, Broward, Palm Beach and Martin County. Furthermore, it will lessen costs of expansion of products and services and increase prescription dispensing efficiency.

Recently, Progressive Care announced that, via its subsidiary Pharmco, LLC, it entered into definitive agreement to purchase a property in Broward County, Florida that will double as the new corporate headquarters and as a retail pharmacy. This third location will facilitate Progressive Care’s growth by expanding its pharmacy operations in the South Florida region.

Progressive Care dispensed 212,000 prescriptions during the nine-month period ending Sept. 30, 2018. This represents an increase over the same period last year of 30 percent. During Q3 2018, it experienced continued growth over last year, showing a 6 percent increase in Total Revenue over Q3 2017. Total Revenue for the nine-month period ending Sept. 30, 2018, was roughly $15.6 million, the largest nine-month period in Progressive Care’s history and an increase of 4 percent over 2017.

Progressive Care, Inc. (RXMD), closed Thursday's trading session at $0.0635, up 8.55%, on 237,498 volume with 22 trades. The average volume for the last 3 months is 1,088,973 and the stock's 52-week low/high is $0.012/$0.2659.

chart

Medibio Limited (MDBIF)

Penny Stock Hub, Stockwatch, OTC Markets, Investing Online, Otc.Watch, InvestorsHangout, Stockhouse, 4-Traders, AwesomePennyStocks, Wallet Investor, The Street, Morningstar, Global Banking and Finance, and TradingView reported previously on Medibio Limited (MDBIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Medibio Limited is a digital health company with offices in Melbourne (Vic), and Minneapolis, Minnesota. It has developed an objective testing system to assist in the screening, diagnosis, and treatment effectiveness of depression, chronic stress, and other mental health disorders. The test uses patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to assist in clinical diagnosis.

The Company is on track to commercialize its platform technology called the Digital Mental Health Platform. The foundation of this is on patented biomarkers from the autonomic nervous system. Medibio’s technology will provide a Diagnosis Aid to help General Practioners (GPs) and mental health clinicians. Medibio’s technology provides the first objective measure of stress. It provides a series of user and corporate dashboards for assessment and wellness partner interventions.

Pertaining to biomarker based objective diagnosis, a panel of circadian, sleep, and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on the physiologic state. The Company’s Digital Mental Health Platform is a device agnostic platform. It can ingest data from manifold devices. It is highly scalable, low cost, and also easy to integrate.

Medibio announced in March 2018 that it signed a term sheet to acquire Vital Conversations Pty Ltd. The acquisition will create a new corporate health offering for Medibio. The new offering combines the psychological health content and digital platform of Vital Conversations with Medibio’s mental health technology platform and exclusive objective mental health measurement and monitoring capabilities.

In October, Medibio announced the release of ilumen™. This is the Company’s product and platform for corporate customers. ilumen™ is a corporate wellness product providing employers the ability to offer biometric analysis and objective, data-driven feedback along with a mental wellness assessment to their employees.

This upgraded platform enables employees to access and monitor this data from their personal devices, measuring and tracking biometrics via the use of wearable technology over a period of time. Participants can actively learn about coping strategies, resources, and personal development plans to better manage stress and strain from life and work.

In early November, Medibio announced the appointment of Mr. David B. Kaysen as Chief Executive Officer (CEO) and Managing Director. Mr. Kaysen brings over 35 years of experience leading and managing domestic and international emerging growth companies. He is experienced in the Food and Drug Administration (FDA) approval process, leading products in revenue growth, and he has experience in Australia. Before joining Medibio, Mr. Kaysen served as President, CEO and Director of Sun BioPharma, Inc.

Medibio Limited (MDBIF), closed Thursday's trading session at $0.0275, even for the day. The average volume for the last 3 months is 11,230 and the stock's 52-week low/high is $0.0275/$0.28.

chart

Blue Line Protection Group, Inc. (BLPG)

Penny Stock Tweets, AwesomePennyStocks, Barchart, New Cannabis Ventures, Marijuana Stocks, Stockwolf, Marketwired, YCharts, Capital Cube, Cannabiznetwork, and Dividend Investor reported on Blue Line Protection Group, Inc. (BLPG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Blue Line Protection Group, Inc. provides consulting, armed security, compliance and investigations, transportation, and secure vaulting services to banks, businesses and government entities. The Company’s professional team consists primarily of former military and law enforcement personnel with decades of experience in protection, investigations, logistics, and tactical industries. Blue Line Protection Group is headquartered in Denver, Colorado.

Blue Line works side-by-side with retail establishments. The Company reduces the risk of criminal activity and creates a secure retail experience through protecting businesses on-site and securing their assets on the road. Blue Line helps retailers remain compliant with all applicable laws. Additionally, the Company shows retail establishments how to protect their businesses through letting Blue Line assume the responsibility and liability for their protective services.  

The Company serves banks and credit unions through providing currency processing and transportation solutions. Its risk mitigation services help financial institutions serving cash-intensive industries comply with federal “know your customer” mandates. Blue Line acts on behalf of banks and credit unions through collecting cash sales revenue from their client locations. Upon collecting the currency, Blue Line transports it to one of its secure processing facilities. It provides currency handling and validation services for the bank and transportation of processed currency to the Federal Reserve.

Blue Line Protection Group and Hypur have plans to open a cash vaulting and processing facility. This is to serve marijuana-related businesses (MRBs) and cash-intensive businesses (CIBs) in the State of Nevada. Blue Line plans to partner with Hypur to expand services to Arizona, Oregon, Washington, California and Nevada. Hypur is a financial technology (FinTech) company headquartered in Scottsdale, Arizona. The new Nevada facility will implement “Hypur Vault” cash management technologies. 

At the end of October, Blue Line Protection Group announced that its Cash In Transit (CIT) operations, including vaulting, processing, and tactical compliance, is now available in Arizona. The Company is serving multiple financial institutions in Arizona. Moreover, it is advancing plans for further expansions next year.

Mr. Dan Allen, Blue Line Protection Group Chief Executive Officer, said, “We’re excited to now be providing services to clients in Arizona and Colorado while continuing our growth into California and Nevada. As demand for our services strengthens, we look forward to meeting the needs of cannabis businesses and financial institutions in these markets.”

Blue Line Protection Group, Inc. (BLPG), closed Thursday's trading session at $0.0022, up 4.76%, on 2,334,034 volume with 28 trades. The average volume for the last 3 months is 8,138,590 and the stock's 52-week low/high is $0.0011/$0.1199.

chart

Premier Gold Mines Limited (PIRGF)

Hotstocked, Stockwatch, Capital Cube, The Street, Market Screener, Stockscores, Stockhouse, Stock Target Advisor, InvestorsHub, The Northern Miner, 4-Traders, Trader Planet, and Barchart reported on Premier Gold Mines Limited (PIRGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Premier Gold Mines Limited is a gold producer and exploration and development company. It has a high-quality pipeline of precious metal projects. These projects are in proven, accessible and safe mining jurisdictions in the U.S., Canada, and Mexico. Listed on the OTC Markets, Premier Gold Mines is headquartered in Thunder Bay, Ontario.

The Company’s team focuses on creating a low‑cost, mid-tier gold producer through its two producing gold mines, and two advanced multi-million-ounce development projects where permitting and pre-construction initiatives are taking place. Premier Gold’s important North American-based assets are along Nevada's Carlin and Battle Mountain-Eureka Trends and in the Sonora State of Mexico. The Company’s Canadian-based projects explore the Superior Geological Sub-Province of Ontario. This is one of the world’s most richly-endowed mineral regions.

Premier Gold Mines’ production properties are South Arturo and Mercedes. Its advanced exploration & development properties are Greenstone Gold and Cove. The Company’s exploration properties are Rahill-Bonanza, McCoy-Cove, Hasaga, and Goldbanks. Premier has entered into a Nevada-focused exploration and development agreement with Barrick Gold Corporation (ABX), through a number of wholly-owned subsidiaries.

Last month, Premier Gold Mines announced its Q3 production results for 2018. The Mercedes Mine produced 17,465 ounces of gold. This represents a 26 percent increase over Q2 2018. South Arturo produced 2,635 ounces of gold from Phase 2 stockpiles. The Company had total silver production of 89,512 ounces.

Production from South Arturo has surpassed annual guidance, benefitting from a decision to fast-track processing of the Phase 2 ore stockpile. Premier Gold Mines remains on course to meet its 2018 consolidated guidance of 90,000-100,000 ounces of gold because of increased production from South Arturo and decreased production expected from Mercedes.

Mr. John Begeman , Executive Chairman of Premier Gold Mines, said, "Overall gold production during the third quarter met expectations with additional ore being processed from stockpiles at the low-cost South Arturo mine. In addition, development and construction commenced on the next two production phases at South Arturo; the Phase 1 open pit and the El Nino underground mine".

Premier Gold Mines Limited (PIRGF), closed Thursday's trading session at $1.2633, up 1.06%, on 20,120 volume with 20 trades. The average volume for the last 3 months is 45,709 and the stock's 52-week low/high is $1.23/$3.089.

chart

Geospatial Corp. (GSPH)

HotStockChat, SmallCapVoice, Penny Sleuth, and The Street reported earlier on Geospatial Corp. (GSPH), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Geospatial Corp. is a leading innovator of asset management/analytics/mapping software and 3D mapping technologies. The Company utilizes integrated technologies to determine the accurate location and position of underground pipelines, conduits, and other underground infrastructure data. This allows it to create accurate three-dimensional (3D) digital maps and models of underground infrastructure. Geospatial is based in Sarver, Pennsylvania. The Company’s shares trade on the OTC Markets’ OTCQB.

Geospatial provides integrated data acquisition technologies. These technologies accurately locate and map underground and aboveground infrastructure assets, including pipelines and surface features by way of its GeoUnderground Cloud-Based Portal. The design of GeoUnderground is around the Google Maps API. GeoUnderground is Geospatial’s cloud-based Geographic Information System (GIS) platform. It provides clients with a complete solution to their underground and aboveground asset management needs.

The Company has new Quality Assurance (QA) and Installed Locational Integrity Management (ILIM) programs for underground pipelines. It provides comprehensive QA programs and ILIM programs for underground pipelines and conduits installed via Horizontal Directional Drilling (HDD) methods irrespective of depth, material, or soil conditions. The service addresses the need for accurate 3D mapping of critical pipeline segments, which exceeds regulatory requirements and supports integrity and reliability demands.

Geospatial utilizes a collection of data acquisition tools and the Company cost-effectively maps most pipelines to an accuracy of less than 10 cm (3.9 inches). Its technologies map HDPE – PVC or metallic underground pipes and conduits from 1-inch diameter and greater to depths of 50 feet (15 m). Geospatial manages the critical infrastructure data on GeoUnderground.

GeoUnderground is a robust Cloud-Based GIS database. This database allows users to view and use this 3D pipeline mapping information securely from any desktop or mobile device.

This past August, Geospatial announced that it completed the mapping of three pipelines under the Savannah River for an industrial facility in Savannah, Georgia. The project concluded in late August. This project had a value of roughly $125,000 in revenue to the Company.

The client is an international industrial corporation. It selected Geospatial along with Jacobs Engineering from a number of companies to perform the technical task of mapping one effluent waste pipeline and two bundled high-voltage conduits. These all run underneath the Savannah River.

Geospatial has been approved as a vendor for IGAPP, which is run by Engility Holdings, Inc. in support of the National Geospatial-Intelligence Agency's (NGA's) mission. NGA is a combat support agency under the U.S. Department of Defense and an intelligence agency of the United States Intelligence Community. Its main mission is collecting, analyzing, and distributing geospatial intelligence in support of national security.

Recently, Geospatial announced the addition of Mr. Rob Brook, an internationally recognized infrastructure and utility industry veteran, to the Company's executive management team. Mr. Brook, who will serve as Team Lead GeoUnderground, Geospatial’s proprietary cloud-based GIS software, is a former Senior Director – Gas Infrastructure for Pacific Gas & Electric (PG&E).

In addition, Mr. Brook served as the Global Pipeline and Gas Utilities Industry Manager for ESRI, the GIS software industry leader. Moreover, he has served on the Board of the Pipeline Open Data Standard (PODS). Mr. Brook has developed a strong understanding of enterprise IT (Information Technology), asset management, public works, pipelines, and gas utilities integrity management solutions.

Geospatial Corp. (GSPH), closed Thursday's trading session at $0.022, up 36.65%, on 31,040 volume with 1 trade. The average volume for the last 3 months is 48,284 and the stock's 52-week low/high is $0.0141/$0.048.

chart

Almost Never Films, Inc. (HLWD)

The Street, YCharts, MarketWatch, and Marketbeat.com reported on Almost Never Films, Inc. (HLWD), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Almost Never Films, Inc. is an independent film company based in Los Angeles, California. Its emphasis is on film production and production related services in connection with production costs in the $5.0 million to $50.0 million range. The Company’s business is to enable relationships between creative talent and companies who produce, finance, and distribute motion pictures. Almost Never Films lists on the OTC Markets.

The Company’s intention is to create, acquire, or license rights to materials upon which it believes motion pictures can be based. Mr. Danny Chan is the Chief Executive Officer (CEO) of Almost Never Films. He is also a Managing Director of Iconic Private Equity Partners, headquartered in Hong Kong. Mr. Chan has spent more than 11 years investing and advising Greater China companies.

Almost Never Films and Saisam Entertainment are partnering to develop and produce the motion picture project "Love Is Not Easy." Danny Chan, Frank Gillen, and Brian Hooks, President of Saisam Entertainment, will serve as lead producers of the film. Brian Hooks will also be engaged as the writer and director of the movie.

Almost Never Films will make financial contributions and participate in the development and production process to make the movie a box office success. Saisam Entertainment will contribute its development and producing services and the original screenplay.

Almost Never Films announced this past June that it provided a portion of bridge financing via The Money Pool and Blue Rider San Juan for the feature film “Ana.” The film stars Dafne Keen who earlier appeared in “Logan” with Hugh Jackman.

Almost Never Films also announced in June that it agreed to provide a portion of Bridge financing via The Money Pool and Blue Rider San Juan, for the motion picture “Speed Kills.” The movie will be directed by John Luessenhop. He previously directed Texas Chainsaw 3D and Takers. “Speed Kills” follows the life of speedboat racing champion Don Aronow played by John Travolta.

Last month, Almost Never Films announced that it entered into a strategic partnership with Pure Flix Entertainment. The new partnership is a multi-film financing agreement to produce six faith-based original motion pictures. Pure Flix Entertainment is an American independent Christian film and television studio, based in Scottsdale, Arizona.

Almost Never Films will contribute its financial, development, as well as production services. Pure Flix Entertainment will distribute the films internationally in new media format.

Today, Almost Never Films announced it is teaming with Howard and Karen Baldwin of KEMB PRODUCTIONS, Stuart Benjamin Productions, and Mr. Nick Cassavetes to develop a scripted television series. Mr. Cassavetes will write the pilot. He is also attached to direct the television series.

The pilot follows the rise and fall of Mr. Bruce McNall, a self-made tycoon who owned the Los Angeles Kings of the National Hockey League (NHL). He was also heavily involved in the high profile worlds of antiquities, coins, race horses, film, and sports.

Almost Never Films, Inc. (HLWD), closed Thursday's trading session at $0.99, up 5.32%, on 1,100 volume with 2 trades. The average volume for the last 3 months is 750 and the stock's 52-week low/high is $0.30/$1.75.

chart

The QualityStocks Company Corner

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce a supply partnership with Velvet Management Inc. for sales and distribution to provincial liquor and cannabis boards across Canada. Velvet is a new company with distinct ownership created by the largest wine distributor in Canada, Philippe Dandurand Wines. Also today, the company was highlighted in a story discussing the news that sales in cannabis-infused edibles products have been on the rise in adult-use legalization markets, with sales projected to surpass $4.1 billion by 2022.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.704, up 10.37%, on 1,126,447 volume with 1,666 trades. The average volume for the last 3 months is 1,485,287 and the stock's 52-week low/high is $1.87/$7.8937.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSX.V: RIV) was featured today in a report by CannabisNewsWire which examines how Canada has seen a number of cannabis cultivators shifting to the use of greenhouses instead of growing the crop in indoor grow rooms. This new development could mark the final days for the cannabis black market in Canada and elsewhere.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.05, up 7.69%, on 337,465 volume with 527 trades. The average volume for the last 3 months is 474,766 and the stock's 52-week low/high is $3.187/$11.82.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced it has achieved its second major milestone in the development of its proprietary Ultra Shear Technology ("UST") platform and commercialization program.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.25, up 8.33%, on 5,820 volume with 17 trades. The average volume for the last 3 months is 2,887 and the stock's 52-week low/high is $2.59/$5.00.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Growing Cannabis Industry Creates Space for New Strategies,” featuring Youngevity International, Inc. (NASDAQ: YGYI). To hear the CannabisNewsAudio version, visit: http://cnw.fm/3cJBj. To read the full editorial, visit: http://cnw.fm/mTv4l.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.88, up 5.85%, on 85,425 volume with 560 trades. The average volume for the last 3 months is 534,596 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted today in a report by Financialnewsmedia.com covering the news that  California is quickly becoming the largest cannabis market in the U.S. while Canada is projected to show strong sales as well since legalization took place in October.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.33, up 7.26%, on 253,868 volume with 315 trades. The average volume for the last 3 months is 934,324 and the stock's 52-week low/high is $0.95/$2.79.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Hemp-cultivated cannabinoid innovator Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) this morning announced its corporate business update for Q4 2018, including completed milestones and strategic initiatives that are underway. Among the highlights, the update provided details on the company’s expanded marketing and public relations strategy. To view the full press release, visit: http://nnw.fm/Bufr5.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.44385, up 6.18%, on 56,282 volume with 36 trades. The average volume for the last 3 months is 119,009 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) was highlighted today in a report discussing how the US will be demanding more from its miners in the wake of the newly signed U.S.-Mexico-Canada trade agreement (USMCA). Increased demand from the US alone for critical metals could likely attract more attention towards miners of new energy metals.

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Leadership

Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $0.99, up 5.10%, on 22,257 volume with 26 trades. The average volume for the last 3 months is 52,707 and the stock's 52-week low/high is $0.604/$2.13.

Recent News

chart

Generation Alpha, Inc. (GNAL)

The QualityStocks Daily Newsletter would like to spotlight Generation Alpha, Inc. (GNAL).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Generation Alpha, Inc. (OTCQB: GNAL), a client of CNW focusing on bringing products and solutions to commercial cannabis growers in legal markets across the United States. To view the full publication, titled “Political Wins Hold Promise for Strong Cannabis Strategies,” visit: http://cnw.fm/UxMb6.

Generation Alpha, Inc. (GNAL) was established in 2010 as a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to both commercial and individual growers in the United States. Originally named Solis Tek Inc., the company changed its name to Generation Alpha in September 2018 and announced an increased focus on providing innovative and must-have cannabis products and services to a growing industry.

“Generation Alpha for us means ‘new beginning’” said Generation Alpha CEO Alan Lien, when the name change was announced. “It is the new wave of how people and brands connect. We are excited with the transformation of our business strategy, our progress at our Arizona facility and the additional growth opportunities our team has identified elsewhere in the cannabis industry. While we are pleased with our innovation and progress in our Solis Tek lighting and Zelda Horticulture divisions, we believe?Generation Alpha?represents our philosophy of bringing the best cannabis products and services to the market. We are confident that this shift in our business strategy will create long-term shareholder value through diversified segments in the legalized cannabis industry.”

The name change reflects the company’s strategy to leverage business opportunities in different legalized cannabis spaces, including cultivation, processing and retail facilities. As part of that focus, Generation Alpha acts as the holding entity for a collection of companies that bring products and solutions to legal retail and commercial cannabis growers while utilizing its expertise to offer safe, quality and consistent products through its cultivation, processing, and retail facilities as well as branded products in both the medical and recreational markets. Along with its strong focus on the burgeoning cannabis market, Generational Alpha remains committed to developing and providing innovative products and services in both Solis Tek Digital Lighting, its lighting division, and Zelda Horticulture, its agricultural products division.

As part of a key piece of its cannabis focus, Generation Alpha acquired a cannabis cultivation and processing facility in Phoenix, Arizona, which is scheduled to begin operation in 2019. Currently in the design and development stage, the 70,000-square-foot facility will be one of the most technologically advanced cultivation and processing facilities in Arizona, which is a hot bed of cannabis cultivation in North America. Generation Alpha management is confident about the growth and profitability this facility provides as an essential component of its forward-thinking cannabis strategy.

Additional components of this strategy include the company’s GrowPro Solutions, Inc., a nationwide cannabis cultivator and processor and a variety of Generation Alpha brands, which include the innovation, design and selling of cannabis?products such as flower, oils and accessories in the legal medical and recreational markets.

The company’s Zelda Horticulture division offers commercial-grade rolling tables, greenhouses, PH stabilizer and nutrient products, and other agricultural products for cultivators around the world. Zelda’s custom-design cultivation options means its clients can count on increased agricultural productivity and efficiency.

Generation Alpha’s Solis Tek Digital Lighting division offers an extensive line of lighting equipment and accessories, including digital ballasts, reflectors,?complete lighting systems, single- and double-ended digital lamps, controllers and other accessories.?Each product is designed to help retail and commercial growers maximize quality and achieve higher yields and maximize quality.?

Redfund Capital Corp. (GNAL), closed the day's trading session at $0.52, up 1.96%, 30,775 volume with 21 trades. The average volume for the last 3 months is 61,271 and the stock's 52-week low/high is $0.40/$2.64.

Recent News

chart

Victory Marine Holdings Corp. (VMHG)

The QualityStocks Daily Newsletter would like to spotlight Victory Marine Holdings Corp. (VMHG).

Victory Marine Holdings Corp. (OTC: VMHG) is a recreational marine provider engaged in yacht sales for both new and used boats, brokerage and consultancy services. Located in Miami, Florida, the company has a large inventory of boats, offers insurance services to yacht owners and offers financing arrangements to buyers. With over 20 years of combined industry experience, Victory Marine’s team is set to capture its fair share of the market through negotiated partnerships with manufacturers.

Victory Marine Holdings Corp. (VMHG) is a world-class yacht sales, brokerage and consulting firm with a sprawling inventory of new and used boats, financing, insurance, documentation and recreational marine accessories. Located in Miami, Florida – the “yacht capital of the world” – Victory Marine has over 20 years of experience in an industry hailed as “an American pastime and economic engine” by the National Marine Manufacturers Association (“NMMA”).

According to the NMMA, marine sales reached $39 billion in 2017. To capture its share of this market, Victory Marine has established partnerships with several selective manufacturers and is pursuing opportunities for vertical growth. While the company’s near-term focus is on expansion of its inventory and sales team, its longer-term plans reflect the current state of the broader yacht industry.

Marine sales are at a 10-year high, and though yacht manufacturers are operating at full capacity, delivery of some products can take longer than 18 months. As a result, Victory Marine is taking steps to establish its own pipeline. Management is currently in negotiations with several yacht manufacturers to build the company its own unique, private-label design, which would enable Victory Marine to quickly deliver a superior product to its clients.

Demand for recreational boat trailers is also on the rise, with growth reported for nearly all powerboat segments. Florida continues to ride the top of that crest with sales of powerboats, trailers, and accessories up 10 percent in 2017 to $2.9 billion, followed by Texas ($1.7 billion) and Michigan ($982 million).

Victory Marine’s wholly owned Excalibur Trailers USA subsidiary is set to take advantage of this market, and is approved by the Society of Automotive Engineers (SAE International) to build custom marine aluminum trailers for recreational boats, as well as for commercial boat transport. Excalibur Trailers USA has filed the necessary paperwork to trademark its brand name and logo and is seeking a suitable manufacturing facility in South Florida for production of powerboat, sailboat, catamaran, powerboat and Jet Ski trailers.

Leading Victory Marine to capture its share of the market is company CEO Orlando Hernandez, whose experience in the marine industry includes negotiation, business planning, investor relations, operations management and sales. He is joined by veteran yacht broker Gary Beaver, who has more than 20 years of successful yacht sales and industry experience. Beaver brings to Victory Marine his portfolio of approximately 25 vessel listings, valued in excess of $10 million.

Victory Marine Holdings Corp. (VMHG), closed the day's trading session at $0.09, up 1.12%, on 33,655 volume with 17 trades. The average volume for the last 3 months is 60,386 and the stock's 52-week low/high is $0.058/$0.97.

Recent News

chart

United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL)

The QualityStocks Daily Newsletter would like to spotlight United Battery Metals Corp. (UBMCF).

United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) was highlighted today in a report discussing how the US will be demanding more from its miners in the wake of the newly signed U.S.-Mexico-Canada trade agreement (USMCA). Increased demand from the US alone for critical metals could likely attract more attention towards miners of new energy metals.

United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) is a vanadium exploration company focused on becoming the first vanadium producer in North America. The company’s flagship project is the Wray Mesa Project, an exploration-stage vanadium property located in Montrose County, Colorado. The property consists of over 107 contiguous mining claims on about 3000 acres. United Battery Metals recently announced that it has tripled its vanadium rich land package in Colorado and Utah. The claims are located on land where both the surface and mineral ownership is held by the Bureau of Land Management (BLM) of the U.S. Department of Interior. Valid unpatented mining claims grant the holder the right of mineral possession as allowed by the General Mining Law of 1872, subject to the various state and federal rules and regulations pertaining to mineral exploitation.

Global demand for vanadium as a strategic metal has exploded in recent years. Vanadium price surges have hit recent highs of approximately $22.63 per pound from about $9 per pound last year.? As a result, mining companies are returning to exploration efforts for vanadium.

The Wray Mesa Project area is part of the La Sal Creek District, which has a long history of exploration and production efforts with records showing drill exploration likely started there in the late 1940s with geologists from the U.S. Geological Survey (USGS) and the Atomic Energy Commission, then continued from the 1960s through the 1980s with private sector interests involved. Based on historical records, the Wray Mesa Project appears to have very good to excellent potential with an inferred resource of 500,000 pounds of uranium- and a current estimated vanadium resource of 2,640,000 pounds as per the last 43-101 prepared in 2013 by Anthony Adkins who is a qualified geologist.

The world’s vanadium demand is set to increase significantly as China implements tighter controls over this critical element as it is used in infrastructure to strengthen steel. With trade war tensions mounting, the U.S. will likely be in dire need of a domestic supply of vanadium for use in steel plants opening nationwide and grid power storage. In fact, the White House has deemed vanadium one of 35 critical elements to United States national and economic security (USGS). US Steel announced additional plants opening nationwide, and this bull market in domestic steel production is likely to increase the demand for a domestic source of vanadium as China has begun restricting vanadium exports to the U.S. amid mounting tensions between the two countries over tariffs and certain critical elements such vanadium.

UBM utilized resource estimation software to model the mineralization detected in a number of the 715 historical and 24 recent drill holes within the project area. Results of the model run, minus the estimated effects of the historic mining, identify an indicated resource of approximately 85,500 short tons at an average grade of 0.16% eU308 for a total of 271,000 pounds of contained uranium. Inferred resources total 57,400 short tons at an average grade of 0.15% of eU308 for a total of about 169,000 pounds of contained uranium. The vanadium resource for the two categories, based on a conservative V:U ratio of 6:1, is 1,626,000 (O.95% average grade) and 1,014,000 (0.88% average grade) pounds, respectively.

Vanadium has multiple uses in modern society including being used in vanadium redox flow batteries (“VRFBs”), car charging stations, nuclear power plants and in steel manufacturing. An article in Mining.com notes that vanadium pentoxide (V2O5), which is used in the production of VRFBs used in energy storage systems, breached US$20 a pound in September 2018 for the first time since 2005, a four-fold increase from the start of 2017.

California recently announced that all homes and mid rises must install solar panels by 2020. Vanadium redox flow batteries (VRFBs) are by far the most superior batteries for large scale energy storage systems and the reason why the Vanadium Redox Flow batteries will dwarf the lithium battery demand. California was the first to announce this green initiative and many experts expect that the revolution will be implemented nationwide in the near future.

Vanadium is one of the 35 minerals deemed critical to the national security and economy of the United States. Among the important uses of vanadium are the following:

  • Fast-charging VRFBs have unique characteristics making them especially attractive when compared to conventional batteries. VRFBs can operate at any temperature, be charged and discharged at the same time, have greater design flexibility and a 25-plus year lifecycle. VRFB’s promise to be a major player in the green energy storage revolution because they are 100 percent reusable, recyclable, are nonflammable, compact, able to provide large grid energy storage, can be fully contained and are seen as a viable alternative to lithium-ion batteries.
  • VRFBs can be used in a variety of energy storage applications including microgrids, during peak shaving periods and for load leveling, as an uninterruptible power supply, for wind and solar farms, and as an off-grid power supply.
  • Approximately 85 percent of vanadium produced is used as ferrovanadium or as an additive to strengthen and harden steel used for applications in axles, crankshafts, gears, surgical instruments and tools, knives, jet engines, high-speed airframes, dental implants, and in seamless tubing for the aerospace, defense and bicycle industries.
  • Vanadium alloys are used in nuclear reactors because of the metal’s low neutron-absorbing properties.

The management team at United Battery Metals Corp. includes president, CEO and Director Matthew Rhoades, the former State Geologist for New Mexico and an accomplished professional geologist with direct working experience in exploration and development projects at numerous deposits and mines throughout the American West, Canada, Mexico and South America. He is joined by George Sharpe, a qualified Mineral Exploration Geoscientist, QP, MCIM and CGT, with over 23 years of global mineral exploration in iron coal, gold, base metals, rare earths, uranium, PGE’s, diamonds, iron and industrial minerals.

United Battery Metals Corp. (UBMCF), closed the day's trading session at $0.89, off by 1.93%, on 303,855 volume with 324 trades. The average volume for the last 3 months is 110,971 and the stock's 52-week low/high is $0.65/$1.58.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces a new partnership with Dermagate of Québec, Canada, to manufacture Hygee™, ETST’s new medical device designed to test women for sexually transmitted infections (STIs). Dermagate (http://www.dermagate.com/) and Pharmagate Group already hold an ISO 13485:2013 certification and has all the necessary knowledge, experience and manufacturing equipment to begin the industrial production of Hygee™.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.00, off by 3.85%, on 31,522 volume with 45 trades. The average volume for the last 3 months is 115,244 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint, Inc. (OTCQB: SING) this morning announced that its SingleSeed.com subsidiary has added three new products to its e-commerce site. Per the update, the three new additions include CBD Naturals Alkaline Water, available in three-, six- and 12-packs; a SingleSeed-branded full spectrum tincture; and Renew CBD Serum. To view the full press release, visit: http://nnw.fm/Jj8rQ.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0229, off by 0.87%, on 4,249,207 volume with 161 trades. The average volume for the last 3 months is 4,457,950 and the stock's 52-week low/high is $0.0226/$0.133.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Sugarmade, Inc. (OTCQB: SGMD), a client of CNW investing in products and brands with disruptive potential. To view the full publication, titled “Hydroponics Increasingly Key as Booming Cannabis Sector Goes to Next Level,” visit: http://cnw.fm/f4D9S. Also today, NetworkNewsWire released a report on the company detailing how Sugarmade, with its move into the industrial hemp space, anticipates increased benefits for its shareholders from this acquisition and recently increased its revenue guidance for calendar year 2019 from $30 million to $70 million (http://nnw.fm/1xIdB).

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0998, off by 6.64%, on 1,420,822 volume with 149 trades. The average volume for the last 3 months is 2,586,040 and the stock's 52-week low/high is $0.05/$0.43.

Recent News

chart

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

Consumer efforts to protect themselves from cybercrime often come down to the familiar requirement of establishing secure passwords and changing them with regularity, accompanied by software designed to ferret out potential cyberattacks. Nevertheless, from individual home computers to large corporate networks, modern tech users continue to fall prey to malicious data miners, which has, in turn, increased demand for more advanced products offered by cybersecurity companies such as Cyberfort Software, Inc. (OTC: CYBF). Also today, the company was highlighted in a report from Investorideas.com looking at the cybersecurity sector, where Juniper Research has projected that the average cost of a data breach in 2020 will exceed $150 million as more business infrastructure gets connected.

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.50, off by 34.21%, on 49,665 volume with 53 trades. The average volume for the last 3 months is 24,904 and the stock's 52-week low/high is $0.051/$69.00.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.